3 ms·

Here's an article about the manufacturing process and its challenges: https://www.economist.com/science-and-technology/2021/02/06/how-vaccines-are-made-and-why-

Here's an article about the manufacturing process and its challenges: https://www.economist.com/science-and-technology/2021/02/06/how-vaccines-are-made-and-why-it-is-hard https://www.economist.com/science-and-technology/2021/02/06/... The Economist isn't a technical publication but it is known to do its homework and get details like this right.

KirillPanov 5y ago
Wow, this is a much better article than the one from the NYTimes. Thank you. Especially for this gem: Supplies of raw materials such as nucleotides are also tight. According to Dr Zarur, Thermo Fisher, an American chemical-supplies company, has spent $200m on a new facility in Lithuania to make these molecules, though the firm itself would not confirm this. I would not have expected this, but it definitely explains a whole lot of otherwise-cryptic claims being made in the WTO debate. I guess it does sort of make sense. The worldwide demand for pure bulk nucleotides probably shot up hundreds or thousands-fold as a result of COVID-19 vax manufacturing.